letter

Cango Inc. Releases Letter to Shareholders

HONG KONG, Nov. 6, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today released a letter to shareholders at the one-year milestone…

4 hours ago

Capital A explores Bahrain as Middle East aviation, engineering and logistics hub to advance global expansion plans

Transportation and Telecommunications from the Kingdom of Bahrain, underscoring the tremendous potential of this partnership and Bahrain's role as a…

5 days ago

Vocodia Holdings Corp. and Scale Agile Solutions Announce Letter of Intent for Strategic Asset Acquisition

October 17, 2025 09:00 ET  | Source: Vocodia Holdings Corp. BOCA RATON, Fla., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Vocodia…

3 weeks ago

Jefferies Provides Letter from Its CEO and President Regarding Point Bonita Capital and First Brands Group

NEW YORK--(BUSINESS WIRE)--Jefferies Financial Group, Inc. (NYSE: JEF) (“Jefferies”) announced today that is has posted this letter from our CEO,…

4 weeks ago

Deakin University and Government of Telangana Announce Intent to Advance AI Innovation in India

HYDERABAD, India, Sept. 8, 2025 /PRNewswire/ -- In a significant step towards strengthening Australia–India cooperation in the field of Artificial…

2 months ago

Vaxart Granted Extension by Nasdaq to Regain Compliance

August 29, 2025 08:00 ET  | Source: Vaxart, Inc. - Company must regain compliance with the Nasdaq Bid Price Rule…

2 months ago

Ancora Issues Letter to CSXs Board of Directors Regarding the Need to Avert a Permanent Impairment of Value and Aggressively Pursue a Value-Maximizing Merger

Asserts the Board Should Immediately Announce the Formal Retention of an Investment Bank and Plan to Vigorously Explore Mergers as…

3 months ago

IOC reaffirms commitment to advancing sustainable development through sport at the local level

25 July 2025 - Building on its ongoing efforts to support sustainable development through sport, the International Olympic Committee (IOC) has…

4 months ago

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

July 11, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…

4 months ago

Prime Success Responds to Sinovac Biotechs False and Misleading Claims

For More Information, Visit www.SaveSinovac.comHONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its affiliates, “Prime Success” or “we”), a significant shareholder…

5 months ago